Liraglutide in Adolescents With Type 1 Diabetes
NCT02516657
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
Liraglutide
Sponsor
University at Buffalo